The correlation between elevated IL-6 levels and impaired RV function was highlighted in the study by Prins et al., 2017, which demonstrated the role of the inflammation–fibrosis axis (via the JAK/STAT pathway) in the pathogenesis of RVD among patients with IR and PAH [18]. This evidence concerns the gene IL6 and pulmonary arterial hypertension.